Header Ads Widget

Responsive Advertisement

Eli Lilly's lead in the obesity race gets wider after another win against rival Novo Nordisk

Lilly shares rose more than 4% Monday, while rival Novo Nordisk tanked.

Post a Comment

0 Comments